Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
13.
Minerva Med ; 74(14-15): 783-6, 1983 Apr 07.
Article in Italian | MEDLINE | ID: mdl-6835566

ABSTRACT

After a brief physiopathological introduction, the results obtained with Cimetidine in 171 cases of peptic oesophagitis are described. Given the high percentage of successes even in serious oesophagitis and the minimal incidence of side effects, cimetidine is the therapy of choice in conservative treatment of peptic oesophagitis.


Subject(s)
Cimetidine/therapeutic use , Esophagitis, Peptic/drug therapy , Guanidines/therapeutic use , Adolescent , Adult , Aged , Drug Evaluation , Esophageal Stenosis/drug therapy , Esophagitis, Peptic/classification , Female , Humans , Male , Middle Aged , Time Factors
14.
Minerva Med ; 74(14-15): 787-90, 1983 Apr 07.
Article in Italian | MEDLINE | ID: mdl-6132354

ABSTRACT

A double blind test with cimetidine and ranitidine conducted on 60 patients with acid reflux oesophagitis revealed cimetidine to be the more effective. Its success is felt to lie more in the drug's ability to activate defensive factors than in its inhibition of acid secretion.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Cimetidine/therapeutic use , Esophagitis, Peptic/drug therapy , Furans/therapeutic use , Guanidines/therapeutic use , Histamine H2 Antagonists/therapeutic use , Adult , Aged , Drug Evaluation , Esophagitis, Peptic/classification , Female , Humans , Male , Middle Aged , Ranitidine , Time Factors
15.
Minerva Med ; 74(13): 691-3, 1983 Mar 31.
Article in Italian | MEDLINE | ID: mdl-6132353

ABSTRACT

The short and medium term results obtained with ranitidine on 33 duodenal ulcer patients are reported. The results obtained indicate that ranitidine is excellent for initial therapy but there are doubts about its efficacity in the prophylaxis of recurring ulceration during maintenance treatment. In addition, about 9% of the patients suffered side effects to the extent that treatment had to be interrupted.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Duodenal Ulcer/drug therapy , Furans/therapeutic use , Histamine H2 Antagonists/therapeutic use , Adult , Aged , Clinical Trials as Topic , Drug Tolerance , Duodenoscopy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Ranitidine , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...